| Ticker: | PROF |
| Current Price: | $7.42 |
| % Daily Change: | -0.27% |
| Volume (1,000s): | 95.85 |
| Average Volume (1,000s): | 66.57 |
| Market Cap (M): | $271.77 |
| 1/2/2024 Price: | $7.90 |
| Change Since Inception: | -6.08% |
Profound Medical Corp.
2400 Skymark Avenue
Unit 6
Mississauga, ON L4W 5K5
Canada
Profound Medical Corp. is a commercial-stage medical technology company based in Mississauga, Ontario, advancing the standard of care for prostate cancer and BPH.
Our proprietary, FDA-cleared technology, TULSA-PRO®, is the first and only AI-powered, MRI-guided, incision-free robotic ablation system for the ablation of prostate tissue.
TULSA-PRO® gives physicians real-time precision and control, enabling customizable treatments that are both clinically effective and designed to preserve patients’ quality of life.
Now available for maximum reimbursement. Discover the difference.